On Thursday the 4th of October, C2 Capital hosted a luncheon event with keynote speaker; CEO, Founder and a self-confessed sustainability geek, David Soutar.
He has established and grown companies for Philips Electronics, Foster International and Honeywell across Australia and Europe. He’s been advising businesses on energy efficiency and building performance for over a decade. David presented the narrative and rationale of his start-up to an intimate group of attendees.
David Souter covered narrative and economic rationale for their enterprise "Watt Cost”. This product aims to solve the widespread knowledge gap of household energy consumption on the backdrop of rising economic and environmental costs. The solution is a consumer-focused, affordable and accessible "HEM" system. Targeting both B2B and B2C customers to deliver an easy-to-install monitor which remotely controls energy use from any meter with autonomous household appliance detection and energy cost in real time. Currently, the group is fundraising for product market fit following large-scale pilots with a telco, energy retailer and appliance retailer resulting in 500 direct pre-sales.
This informative luncheon gave an opportunity for C2 Capital to engage with a selected group from our network. The guests enjoyed hearing updates from our team members and deal partner over an hour long lunch. Afterwards, the guests had a chance to connect and network with other like-minded people in the room.
Any information or advice contained on this website is general in nature and has been prepared without taking into account your objectives, financial situation or needs. Before acting on any information or advice on this website, you should consider the appropriateness of it (and any relevant product) having regard to your circumstances and, if a current offer document is available, read the offer document before acquiring products named on this website. You should also seek independent financial advice prior to acquiring a financial product. All financial product involve risks. Past performance of any product described on this site is not a reliable indication of future performance.
C2 Portfolio 1 Pty Ltd is the Trustee of the Pakenham Medical Precinct Trust. It holds a Corporate Authorised Representative authorisation from Quay Fund Services Limited (Quay) (AFSL No.494886). C2 Capital Investor Channels Pty Ltd also holds a Corporate Authorised Representative authorisation from Quay allowing it to provide General Product Advice.